(Q51101013)

29 March 2018

title

Major depressive subtypes and treatment response. (English)

1 reference

29 March 2018

author

Jonathan E. Alpert

3

1 reference

29 March 2018

author name string

Fava M

1

1 reference

29 March 2018

Uebelacker LA

2

1 reference

29 March 2018

Nierenberg AA

4

1 reference

29 March 2018

Pava JA

5

1 reference

29 March 2018

Rosenbaum JF

6

1 reference

29 March 2018

language of work or name

English

0 references

publication date

1 October 1997

1 reference

29 March 2018

published in

Biological Psychiatry

1 reference

29 March 2018

volume

42

1 reference

29 March 2018

page(s)

568-576

1 reference

29 March 2018

issue

7

1 reference

29 March 2018

Elevated sleep and waking heart rates in anxious depressions.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900440-4

Follow-up and family study of anxious depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900440-4

Neuroticism and personality disorder in depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900440-4

Therapeutic efficacy of antidepressants in agitated anxious depression--a meta-analysis of moclobemide studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900440-4

Anger attacks in unipolar depression, Part 1: Clinical correlates and response to fluoxetine treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900440-4

Are thymoleptic-responsive "anger attacks" a discrete clinical syndrome?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900440-4

Personality disorder comorbidity with major depression and response to fluoxetine treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900440-4

Lithium and tricyclic augmentation of fluoxetine treatment for resistant major depression: a double-blind, controlled study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900440-4

Fluoxetine treatment of anger attacks: a replication study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900440-4

Exactly what does the Hamilton Depression Rating Scale measure?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900440-4

Prevalence and correlates of anger attacks: a two site study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900440-4

A rating scale for depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900440-4

Response patterns of depressed outpatients with and without melancholia: a double-blind, placebo-controlled trial of fluoxetine versus placebo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900440-4

The overlap between depression and anxiety on different levels of psychopathology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900440-4

Anxious and nonanxious depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900440-4

"Double depression": superimposition of acute depressive episodes on chronic depressive disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900440-4

"Double depression": two-year follow-up

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900440-4

Moclobemide and fluoxetine in atypical depression: a double-blind trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900440-4

Nosology of depression and differential response to drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900440-4

Fluoxetine versus phenelzine in atypical depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900440-4

Melancholic/endogenous depression and response to somatic treatment and placebo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900440-4

Tricyclic nonresponders: phenomenology and treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900440-4

Comparative efficacy of selective serotonin reuptake inhibitors and tricyclics in the treatment of melancholia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900440-4

Melancholic symptom features and DSM-IV.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900440-4

Cluster a personality disorder: a marker of worse treatment outcome of major depression?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900440-4

Can mildly depressed outpatients with atypical depression benefit from antidepressants?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900440-4

Borderline personality disorder in major depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900440-4

Major depressive disorder and panic disorder. Effects of comorbidity on treatment outcome with antidepressant medications.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900440-4

inferred from DOI database lookup

7 January 2021

based on heuristic

Comorbidity of personality disorders and depression: implications for treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900440-4

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0006-3223(96)00440-4

1 reference

29 March 2018

PubMed ID

9376453

1 reference

29 March 2018